Human medicines European public assessment report (EPAR): Hulio, adalimumab, Date of authorisation: 17/09/2018, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Date of authorisation: 20/02/2023, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation: 17/09/2025, Revision: 3, Status: Authorised

Paliperidone palmitate

Human medicines European public assessment report (EPAR): Kauliv, teriparatide, Date of authorisation: 12/01/2023, Revision: 4, Status: Authorised

Recommended submission dates for veterinary medicinal products

Paediatric Committee (PDCO): 23-26 June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 June 2026 to 26 June 2026

PDCO minutes of the 23-26 June 2026 meeting

Committee for Medicinal Products for Human Use (CHMP): 23-26 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 23 February 2026 to 26 February 2026

Annex to 23-26 February 2026 CHMP Minutes